Fireside chat with newly appointed CEO, Thijs Spoor, today, February 22 at 1:30 PM ETCORALVILLE, IA / February 22, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a precision oncology company developing alpha-particle therapies and...